[Chosun Biz Event] 2026 SME AX Leaders Forum to Spotlight AI-Driven Growth Strategies for SMEs
AI Transformation, or AX, is emerging as a key driver of corporate growth and competitiveness as companies across industries seek new ways to scale through artificial intelligence. According to Chosun Biz, the 2026 SME AX Leaders Forum will be held…
Smart Manufacturing Breaks Through, Humans and Machines Converge: Deep Insights Into China’s Collaborative Robot Market in 2026
Standing at a new industrial development inflection point in 2026, industrial automation is undergoing a paradigm shift from “replacing humans with machines” to “human-machine convergence.” China’s collaborative robot (Cobot) industry has swept away the capital gloom of the past two…
Tencent’s AI Second Half Officially Begins: A Revolution About Efficiency
On June 5, 2026, at Phase Two of the Beijing National Convention Center, the 2026 Tencent Cloud AI Industry Application Conference opened under the theme “Agents Enter the Arena, Efficiency Grows.” This is Tencent’s most important annual AI product launch…
Geopolitics, Supply Chains, and the Next Generation of Global Leaders: A Conversation with Professor Joan Jané
As geopolitical tensions, supply chain realignments, and artificial intelligence reshape the global business landscape, corporate leaders are facing unprecedented levels of complexity. What was once a world optimized primarily for efficiency is increasingly being redefined by resilience, risk management, and…
Unitree Rings the Bell First, Agibot Splits Into a Full Industry Chain: Humanoid Robots Face Their Real-World Commercialization Test
2026 is widely recognized by the industry as the decisive year for humanoid robot commercialization. On one side, Unitree Robotics passed its STAR Market IPO review in just 73 days, securing the position of the first humanoid robot stock on…
A Dawn Begins to Break for New Pancreatic Cancer Drugs
At the ASCO 2026 Annual Meeting, clinical data from multiple pancreatic cancer KRAS inhibitors, mRNA vaccines, and immune combination therapies were disclosed in a concentrated manner. The “king of cancers” has gone nearly thirty years without a breakthrough in chemotherapy…
When Computing Power Is “Impossible to Get”: The Frenzy and Hidden Worries of Computing Power Leasing
In today’s world where the AI wave is sweeping the globe, computing power has become the core engine driving industrial transformation. Yet compared with the chip giants or large model companies in the spotlight, one “less glamorous” segment has quietly…
Can Xpeng GX’s “All-or-Nothing” Self-Rescue Succeed?
On May 20, Xpeng launched its flagship full-size SUV, the Xpeng GX, with a limited-time starting price of RMB 269,800 (≈ USD 37,472), slashed by RMB 130,000 (≈ USD 18,056) from the pre-sale price, with all trim levels featuring premium…
The First “Enterprise Decision-Making AI Agent” IPO: Looking Behind the Scenes at Deepexi’s Hong Kong Listing and Its Future
On May 18, 2026, Deepexi, China’s leading AI service provider for marketing and sales decision-making, officially launched its global public offering, with plans to list on the main board of the Hong Kong Stock Exchange on May 27, vying for…
DeepSeek Breaks Through: Models, Funding, and the Reshaping of China’s AI Landscape
In May 2026, all eyes in China’s technology world are fixed on a single name — DeepSeek. This AI company, once defined by its self-imposed labels of “no fundraising, no commercialization,” detonated two explosive announcements within a single month. First…
